A liver biopsy is an outpatient procedure that your doctor may recommend to diagnose an underlying medical condition. The procedure may cause pain, but it’s usually short lasting. Many liver biopsies ...

Expert clinicians remark on the current role of the liver biopsy in the diagnosis of advanced fibrosis due to nonalcoholic steatohepatitis and highlight considerations for utilizing newer, noninvasive ...

Novel biomarker tests have met or exceeded the performance of common lab tests for diagnosing nonalcoholic steatohepatitis (NASH, now known as metabolic dysfunction-associated steatohepatitis or MASH) ...

Traditionally, liver biopsy has played a central role in the management of chronic hepatitis C, reflecting the pivotal place the liver holds as the most significant organ affected by this infection.

Researchers have created a liquid biopsy test, which uses two circulating proteins, to test for major liver diseases. The test was found to be highly accurate, sensitive, and specific for both NASH ...

The popularity of noninvasive options to diagnose liver disease has been growing, but are there times when more traditional methods like liver biopsy are still needed for a precise diagnosis? Medical ...

At the annual Liver Meeting sponsored by the American Association for the Study of Liver Diseases (AASLD), AASLD President Grace L. Su, MD, of the University of Michigan in Ann Arbor, highlighted ...

Roughly 1 in 3 adults has metabolic dysfunction–associated steatotic liver disease, or MASLD. A doctor outlines how to detect ...

Doctors can often diagnose liver cancer with a CT scan and blood tests. A biopsy may be needed if imaging results are inconclusive. Liver cancer is often diagnosed after someone develops symptoms such ...

Please provide your email address to receive an email when new articles are posted on . Agile scores had the highest predictive value and classified fewer patients in the intermediate-risk group vs.

Hepta, a biotechnology company using transformer-based AI to decode the cell-free DNA (cfDNA) epigenome and detect organ-specific signals of chronic disease, today announced the creation of an ...